Publication Listing for the MeSH term Middle Age. Found 188 abstracts
no pagination| Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol. 2003 Sep;98(9):2078-81. |
| Brown TA, Ridge JA, Goldberg M. Gastrostomy-site tumor recurrence is not always fatal. Surg Endosc. 2003 Feb;17(2):351. |
| Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Positive prostate biopsy laterality and implications for staging. Urology. 2003 Aug;62(2):298-303. |
| Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, Meropol NJ. Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol. 2003 Apr;21(7):1301-6. |
| Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res. 2003 Jan;9(1):109-14. |
| Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E, Schilsky RL, Wood WC, Muss HB, Norton L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003 Mar 15;21(6):976-83. |
| Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, Clapper ML, Garte S, Haugen A, Ingelman-Sundberg M, Kihara M, Rannug A, Ryberg D, Stucker I, Sugimura H, Taioli E. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 2003 May;14(4):339-46. |
| Levine EA, Freimanis RI, Perrier ND, Morton K, Lesko NM, Bergman S, Geisinger KR, Williams RC, Sharpe C, Zavarzin V, Weinberg IN, Stepanov PY, Beylin D, Lauckner K, Doss M, Lovelace J, Adler LP. Positron emission mammography: initial clinical results. Ann Surg Oncol. 2003 Jan;10(1):86-91. |
| Manne S, Markowitz A, Winawer S, Guillem J, Meropol NJ, Haller D, Jandorf L, Rakowski W, Babb J, Duncan T. Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model. Prev Med. 2003 Jan;36(1):71-84. |
| McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, Buetow KH. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003 Aug;63(15):4594-601. |
| Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Int J Radiat Oncol Biol Phys. 2003 May;56(1):192-8. |
| Moore-Higgs GJ, Watkins-Bruner D, Balmer L, Johnson-Doneski J, Komarny P, Mautner B, Velji K. The role of licensed nursing personnel in radiation oncology part A: results of a descriptive study. Oncology Nursing Forum. 2003 Jan;30(1):51-8. |
| Pollack A, Hanlon AL, Movsas B, Hanks GE, Uzzo R, Horwitz EM. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Sep;57(1):19-23. |
| Schilder RJ, Brady MF, Spriggs D, Shea T. Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 2003 Jan;88(1):3-8. |
| Schnoll RA, Bradley P, Miller SM, Unger M, Babb J, Cornfeld M. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer. 2003 Mar;39(3):315-25. |
| Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC, Engstrom PF. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the eastern cooperative oncology group. J Clin Oncol. 2003 Jan;21(2):355-65. |
| Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Jul;56(3):755-63. |
| Arnoletti JP, Hoffman JP, Ross EA, Kagan SA, Meropol NJ, Freedman G, Eisenberg B. Preoperative chemoradiation in the management of adenocarcinoma of the body of the pancreas. Am Surg. 2002 Apr;68(4):330-5; discussion 335-6. |
| Augsburger JJ, Correa ZM, Schneider S, Yassin RS, Robinson-Smith T, Ehya H, Trichopoulos N. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category. Trans Am Ophthalmol Soc. 2002 Jan;100:225-32; discussion 232-4. |
| Badawi AF, Habib SL, Mohammed MA, Abadi AA, Michael MS. Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer. Cancer Invest. 2002 Jan;20(5-6):651-6. |
MeSH cloud from publications including the MeSH term Middle Age
Middle Age
Human
Male
Female
Aged
US Gov't Support-PHS
Adult
pathology
methods
drug therapy
radiotherapy
80 and over Aged
therapeutic use
Treatment Outcome
adverse effects
United States
Prostatic Neoplasms
surgery
administration & dosage
Adenocarcinoma
Risk Factors
genetics
Follow-Up Studies
Smoking
Antineoplastic Combined Chemotherapy Protocols
blood
Neoplasm Metastasis
Time Factors
statistics & numerical data
Case-Control Studies
Adjuvant Radiotherapy
Comparative Study
Patient Education
mortality
psychology
diagnosis
Non-US Gov't Support
Needle Biopsy
pharmacology
Pilot Projects
Retrospective Studies
Prostate-Specific Antigen
Neoplasm Staging
Breast Neoplasms
Colonoscopy
Antineoplastic Agents
Conformal Radiotherapy
Smoking Cessation
Proportional Hazards Models
Colorectal Neoplasms
Health Behavior
Adjuvant Chemotherapy
Disease Progression
Pancreatic Neoplasms
toxicity
antagonists & inhibitors
Squamous Cell Carcinoma
Drug Dose-Response Relationship
epidemiology
Survival Analysis
prevention & control
Physician-Patient Relations
Mass Screening
Lung Neoplasms
Risk Assessment
Questionnaires
Paclitaxel
biosynthesis
metabolism
US Gov't Support-Non-PHS
Oncology
Protein Kinase C
Reproducibility of Results
Spiral Computed Tomography
Nurse Managers
Siblings
Differential Diagnosis
Peripheral Blood Stem Cell Transplantation
Remission Induction
Self Efficacy
Knowledge
Choroid Neoplasms
radiography
Cytodiagnosis
Local Neoplasm Recurrence
Filgrastim
Radiodermatitis
Conserved Sequence
Experimental Liver Neoplasms
Cocarcinogenesis
Carcinoma
Tissue Culture
Racial Stocks
Physician's Role
Canada
C-Reactive Protein
Bladder Neoplasms
injuries
Salvage Therapy
Emission-Computed Tomography
Liver Neoplasms
Rectum
dosage
Prostatectomy
Dinoprostone
Preoperative Care
Carrier Proteins
Urothelium
therapy
Prospective Studies
etiology
Anthracycline Antibiotics
Pigmented Nevus
Three-Dimensional Imaging
Amino Acid Sequence
Isoenzymes
Radiotherapy Dosage
physiopathology
Neoplastic Gene Expression Regulation
Occult Blood
Alkyl and Aryl Transferases
Environmental Carcinogens
Convenience Sample
Hepatocellular Carcinoma
Practice Guidelines
Kidney Neoplasms
Prognosis
Fluorouracil
Phytogenic Antineoplastic Agents
Exons
Data Analysis Software
Employment
Staff Nurses
Stomach Neoplasms
radiation effects
Knockout Mice
Androgen Antagonists
Mouth Neoplasms
Cytochrome P-450 CYP1A1
Mammography
Polymerase Chain Reaction
Case Report
Carboplatin
chemically induced
Perception
Quality of Life
Polymorphism (Genetics)
Descriptive Research
Oncologic Nursing
Information Resources
